Scarica l'app Stockscreener
4.85
2.42%
0.10
Precedente Chiudi:
$4.75
Aprire:
$5.33
Volume 24 ore:
235.76K
Relative Volume:
0.10
Capitalizzazione di mercato:
$9.41M
Reddito:
$7.06M
Utile/perdita netta:
$-21.17M
Rapporto P/E:
-0.2031
EPS:
-23.879
Flusso di cassa netto:
$-28.95M
1 W Prestazione:
+2.85%
1M Prestazione:
+1,037%
6M Prestazione:
+440.92%
1 anno Prestazione:
+167.31%
Intervallo 1D:
$4.7232
$5.50
Intervallo di 1 settimana:
$4.37
$5.50
Portata 52W:
$0.1806
$6.74
Curis Inc Stock (CRIS) Company Profile
Nome
Curis Inc
Settore
Industria
Telefono
617-503-6500
Indirizzo
128 SPRING STREET, LEXINGTON, MA
Compare CRIS vs VRTX, REGN, ARGX, RVMD, ALNY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
4.83 | 9.26M | 7.06M | -21.17M | -28.95M | -23.88 |
VRTX
Vertex Pharmaceuticals Inc
|
473.08 | 122.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
652.90 | 70.79B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
855.00 | 54.72B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
183.70 | 38.97B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
265.78 | 36.23B | 4.29B | 577.22M | 641.34M | 4.2086 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-19 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-17 | Iniziato | Truist | Buy |
| 2022-04-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2020-07-29 | Iniziato | Laidlaw | Buy |
| 2020-07-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2016-03-02 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
| 2015-11-09 | Reiterato | ROTH Capital | Buy |
| 2015-08-11 | Iniziato | FBR Capital | Outperform |
| 2015-01-22 | Reiterato | Oppenheimer | Outperform |
| 2015-01-21 | Reiterato | ROTH Capital | Buy |
| 2014-05-09 | Reiterato | Oppenheimer | Outperform |
| 2013-10-02 | Iniziato | Robert W. Baird | Outperform |
| 2013-09-30 | Iniziato | Chardan Capital Markets | Buy |
| 2012-11-14 | Iniziato | Stifel Nicolaus | Hold |
| 2012-01-31 | Reiterato | Brean Murray | Buy |
| 2012-01-31 | Reiterato | Summer Street Research | Buy |
| 2011-12-09 | Iniziato | Oppenheimer | Outperform |
| 2011-10-06 | Iniziato | Summer Street Research | Buy |
| 2011-09-22 | Iniziato | MLV Capital | Buy |
| 2011-03-21 | Reiterato | Brean Murray | Buy |
| 2010-02-26 | Reiterato | Roth Capital | Buy |
| 2010-01-07 | Iniziato | Roth Capital | Buy |
Mostra tutto
Curis Inc Borsa (CRIS) Ultime notizie
Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates - Benzinga
Curis Q2 2026: Updated Clinical Data for Emavusertib Trials - grafa.com
Curis shares surge after updated emavusertib data strengthens clinical outlook (NASDAQ:CRIS) - Yahoo Finance
Curis stock jumps 11% on positive emavusertib trial data By Investing.com - Investing.com South Africa
Curis reports updated trial data for emavusertib in lymphoma - Investing.com
Curis Announces Positive Emavusertib Update - PR Newswire
FRA:CUS1 EPS (Basic): €-20.76 | Significantly Overvalued - GuruFocus
Curis (FRA:CUS1) Graham Number : €N/A (As of Mar. 2026) - GuruFocus
Curis Inc Annual Shareholders Meeting Transcript - GuruFocus
Curis (FRA:CUS1) Marketable Securities : €0.00 Mil (As of Mar. 2026) - GuruFocus
FRA:CUS1 EV-to-EBITDA: 0.69 — 35% Above Median - GuruFocus
Q2 2025 Curis Inc Earnings Call Transcript - GuruFocus
Q1 2026 Curis Inc Earnings Call Transcript - GuruFocus
Q3 2025 Curis Inc Earnings Call Transcript - GuruFocus
Curis Inc (FRA:CUS1) Stock Price & 30 Year Financial Data - GuruFocus
Curis Inc (FRA:CUS1)Valuation Measures & Financial Statistics - GuruFocus
Curis Inc (FRA:CUS1) Stock Earnings Transcripts - GuruFocus
Curis Inc (FRA:CUS1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Equity in earnings of Curis, Inc. – SWB:CUS1 - TradingView
Price to book forward of Curis, Inc. – SWB:CUS1 - TradingView
Long term debt to total equity ratio of Curis, Inc. – SWB:CUS1 - TradingView
Net margin % of Curis, Inc. – DUS:CUS1 - TradingView
Net current asset value per share of Curis, Inc. – DUS:CUS1 - TradingView
Form 4 Curis Inc For: 9 July By Investing.com - Investing.com Nigeria
Director Marc Rubin receives 6,800 Curis (CRIS) stock options at $5.29 - Stock Titan
Curis (CRIS) director receives grant of 6,800 non-qualified stock options - Stock Titan
Curis (CRIS) director John Hohneker receives 6,800 stock options at $5.29 - Stock Titan
Curis Inc (CRIS) director receives 6,800 stock options at $5.29 - Stock Titan
CURIS INC (CRIS) director granted 6,800 non-qualified stock options at $5.29 - Stock Titan
CURIS (CRIS) CFO receives 48,285 stock options at $5.29 exercise price - Stock Titan
Curis (CRIS) CDO Jonathan Zung receives 48,285 stock options at $5.29 strike - Stock Titan
Curis (CRIS) CEO receives 110,090 employee stock options at $5.29 - Stock Titan
Price to book forward of Curis, Inc. – HAM:CUS1 - TradingView
Return on invested capital % of Curis, Inc. – HAM:CUS1 - TradingView
Net income of Curis, Inc. – HAM:CUS1 - TradingView
Free cash flow per share of Curis, Inc. – LSX:A42DTL - TradingView
Price to book forward of Curis, Inc. – FWB:CUS1 - TradingView
Return on assets % of Curis, Inc. – LSX:A42DTL - TradingView
Debt to equity ratio of Curis, Inc. – FWB:CUS1 - TradingView
Return on equity % of Curis, Inc. – FWB:CUS1 - TradingView
Net income of Curis, Inc. – GETTEX:CUS1 - TradingView
Gross profit of Curis, Inc. – FWB:CUS1 - TradingView
Net income of Curis, Inc. – LS:A42DTL - TradingView
Price to book forward of Curis, Inc. – MUN:CUS1 - TradingView
Operating expenses (excl. COGS) of Curis, Inc. – MUN:CUS1 - TradingView
Curis stock edges into a thin-day update. - Ad-hoc-news.de
Number of employees of Curis, Inc. – MUN:CUS1 - TradingView
Basic earnings per share (basic EPS) of Curis, Inc. – MUN:CUS1 - TradingView
Curis, Inc. Income Statement – MUN:CUS1 - TradingView
Curis Inc (STU:CUS1) Stock Earnings Transcripts - GuruFocus
Curis Inc (STU:CUS1) Stock Price & 30 Year Financial Data - GuruFocus
Curis Inc Azioni (CRIS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):